Literature DB >> 28387890

Effects of propofol and dexmedetomidine anesthesia on Th1/Th2 of rat spinal cord injury.

F-Y He1, W-Z Feng, J Zhong, W Xu, H-Y Shao, Y-R Zhang.   

Abstract

OBJECTIVE: Spinal cord injury (SCI) patients had major trauma during surgery, which thus necessitates optimal choice of anesthesia drugs. The specific selection of anesthesia agents may affect body immune system. Therefore, this study aims to investigate the anesthesia effect of propofol and dexmedetomidine on the rat SCI and their effects of Th1/Th2.
MATERIALS AND METHODS: Improved ALLEN's pouching method was used to generate rat SCI model. The SCI rat models were further divided into propofol and dexmedetomidine group for analyzing anesthesia time, duration, post-op analgesia time, SCI sensory function Reuter score. Real-time PCR quantified Th1 secreted cytokines interleukin (IL)-2, tumor necrosis factor (TNF)-α, Th2 secreted cytokines IL-4 and IL-10 mRNA expression levels. Enzyme labeled immunosorbent assay (ELISA) quantified serum cytokine levels. Th1 and Th2 cytokines were analyzed for correlation.
RESULTS: Dexmedetomidine had shorter anesthesia onset time, longer duration time, and elongated post-op analgesia time with lower Reuter score (p<0.05 compared to propofol group). No significant difference existed between heart rate (HR), respiration rate, SpO2, and body temperature (T) during surgery. Compared to dexmedetomidine, propofol had elevated mRNA or serum levels of IL-2 and TNF-α, plus significantly lower IL-4 or IL-10 expression (p<0.05). IL-2 and TNF-α levels were negatively correlated with IL-4 and IL-10 (p<0.05).
CONCLUSIONS: Dexmedetomidine had better effects for improving in-op and post-op anesthesia/analgesia effects than propofol. Both drugs can induce imbalance of Th1/Th2.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28387890

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study.

Authors:  Xiaoyu Zheng; Yu Wang; Linlin Dong; Su Zhao; Liping Wang; Hong Chen; Yang Xu; Guonian Wang
Journal:  Onco Targets Ther       Date:  2018-03-01       Impact factor: 4.147

2.  Analysis of Anesthesia Effect of Dexmedetomidine in Clinical Operation of Replantation of Severed Finger.

Authors:  Tongsheng Xu; Xiaodong Chen; Xin Li; Mingzhu Wang; Meng Wang
Journal:  Comput Math Methods Med       Date:  2021-12-13       Impact factor: 2.238

3.  Propofol Prevents the Growth, Migration, Invasion, and Glycolysis of Colorectal Cancer Cells by Downregulating Lactate Dehydrogenase Both In Vitro and In Vivo.

Authors:  Zhichao Wu; Han Wang; Zu-An Shi; Yalan Li
Journal:  J Oncol       Date:  2022-04-30       Impact factor: 4.501

4.  Effects of Transplanted Heparin-Poloxamer Hydrogel Combining Dental Pulp Stem Cells and bFGF on Spinal Cord Injury Repair.

Authors:  Lihua Luo; Abdullkhaleg Ali Albashari; Xiaoyan Wang; Ling Jin; Yanni Zhang; Lina Zheng; Jianjian Xia; Helin Xu; Yingzheng Zhao; Jian Xiao; Yan He; Qingsong Ye
Journal:  Stem Cells Int       Date:  2018-03-27       Impact factor: 5.443

5.  Modulation of inflammatory factors predicts the outcome following spinal cord injury.

Authors:  Zepeng Yu; Xingwei Sun; Rui Xia; Qian Chen; Qin Wu; Weiwei Zheng
Journal:  J Orthop Surg Res       Date:  2020-06-01       Impact factor: 2.359

6.  Distant survival for patients undergoing surgery using volatile versus IV anesthesia for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study.

Authors:  Xiao-Yan Meng; Xiu-Ping Zhang; Zhe Sun; Hong-Qian Wang; Wei-Feng Yu
Journal:  BMC Anesthesiol       Date:  2020-09-14       Impact factor: 2.217

7.  Hypoxic preconditioned bone mesenchymal stem cells ameliorate spinal cord injury in rats via improved survival and migration.

Authors:  Weiheng Wang; Xiaodong Huang; Wenbo Lin; Yuanyuan Qiu; Yunfei He; Jiangming Yu; Yanhai Xi; Xiaojian Ye
Journal:  Int J Mol Med       Date:  2018-08-07       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.